TriSalus Life Sciences, Inc. (TLSI)
NCM · Common · CUSIP 89680M101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TLSI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
89680M101 (prev. 58507N105 )
IPO
12/18/2020
Previous Symbol
MTAC (changed 8/10/2023)
Previous Name
MedTech Acquisition Corp
Business: TriSalus Life Sciences, Inc. is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors.

Company Contact

CEO
Mary Szela
CFO
James Young
Headquarters
6272 W 91st Ave, Westminster, CO 80031
Phone
888-321-5212 · Toll-Free 888-321-5212
Investor Relations
James Young · 847-337-0655 · james.young@trisaluslifesci.com
General Email
investor.relations@trisaluslifesci.com
SEC EDGAR Filings
View filings »
Find all related securities for TLSI »